Effects of resveratrol and irradiation upon oral squamous cell carcinoma cells

References

• Scully C, Bagan J. Oral squamous cell carcinoma: overview of current understanding of aetiopathogenesis and clinical implications. Oral Dis 2009;15:388–99.
   PubMed Web of Science ®Google Scholar
• Cooper JS, Pajak TF, Forastiere AA, Jacobs J, Campbell BH, Saxman SB, et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 2004;350:1937–44.
   PubMed Web of Science ®Google Scholar
• Lu R, Dan H, Wu R, Meng W, Liu N, Jin X, et al. Lycopene features and potential significance in the oral cancer and precancerous lesions. J Oral Pathol Med 2011;40:361–8.
   PubMed Web of Science ®Google Scholar
• Mgbonyebi OP, Russo J, Russo IH. Antiproliferative effect of synthetic resveratrol on human breast epithelial cells. Int J Oncol 1998;12:865–9.
   PubMed Web of Science ®Google Scholar
• Aggarwal BB, Shishodia S. Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol 2006;71:1397–421.
   PubMed Web of Science ®Google Scholar
• Hu FW, Tsai LL, Yu CH, Chen PN, Chou MY, Yu CC. Impairment of tumor-initiating stem-like property and reversal of epithelial-mesenchymal transdifferentiation in head and neck cancer by resveratrol treatment. Mol Nutr Food Res 2012;56:1247–58.
   PubMed Web of Science ®Google Scholar
• Rubiolo JA, López-Alonso H, Martín-Vázquez V, Fol-Rodríguéz N, Vieytes MR, Vega FV. Resveratrol inhibits proliferation of primary rat hepatocytes in g0/g1 by inhibiting DNA synthesis. Folia Biol (Praha) 2012;58:166–72.
   PubMedGoogle Scholar
• Fremont L. Biological effects of resveratrol. Life Sci 2000;66:663–73.
   PubMed Web of Science ®Google Scholar
• Kundu JK, Surh YJ. Cancer chemopreventive and therapeutic potential of resveratrol: mechanistic perspectives. Cancer Lett 2008;269:243–61.
   PubMed Web of Science ®Google Scholar
• Kovacic P, Somanathan R. Multifaceted approach to resveratrol bioactivity: focus on antioxidant action, cell signaling and safety. Oxid Med Cell Longev 2010;3:86–100.
   PubMed Web of Science ®Google Scholar
• Palsamy P, Subramanian S. Modulatory effects of resveratrol on attenuating the key enzymes activities of carbohydrate metabolism in streptozotocin-nicotinamide-induced diabetic rats. Chem Biol Interact 2009;179:356–62.
   PubMed Web of Science ®Google Scholar
• Estrov Z, Shishodia S, Faderl S, Harris D, Van Q, Kantarjian HM, et al. Resveratrol blocks interleukin-1beta-induced activation of the nuclear transcription factor NF-kappaB, inhibits proliferation, causes S-phase arrest, and induces apoptosis of acute myeloid leukemia cells. Blood 2003;102:987–95.
   PubMed Web of Science ®Google Scholar
• Liang YC, Tsai SH, Chen L, Lin-Shiau SY, Lin JK. Resveratrol-induced G2 arrest through the inhibition of CDK7 and p34CDC2 kinases in colon carcinoma HT29 cells. Biochem Pharmacol 2003;65:1053–60.
   PubMed Web of Science ®Google Scholar
• Elattar TM, Virji AS. The effect of red wine and its components on growth and proliferation of human oral squamous carcinoma cells. Anticancer Res 1999;19:5407–14.
   PubMed Web of Science ®Google Scholar
• Horn TL, Cwik MJ, Morrissey RL, Kapetanovic I, Crowell JA, Booth TD, et al. Oncogenicity evaluation of resveratrol in p53(+/-) (p53 knockout) mice. Food Chem Toxicol 2007;45:55–63.
   PubMedGoogle Scholar
• Chun YJ, Kim MY, Guengerich FP. Resveratrol is a selective human cytochrome P-450 1A1 inhibitor. Biochem Biophys Res Commun 1999;262:20–4.
   PubMed Web of Science ®Google Scholar
• Salado C, Olaso E, Gallot N, Valcarcel M, Egilegor E, Mendoza L, et al. Resveratrol prevents inflammation-dependent hepatic melanoma metastasis by inhibiting the secretion and effects of interleukin-18. J Transl Med 2011;9:59.
   PubMedGoogle Scholar
• Bishayee A, Waghray A, Barnes KF, Mbimba T, Bhatia D, Chatterjee M, et al. Suppression of the inflammatory cascade is implicated in resveratrol chemoprevention of experimental hepatocarcinogenesis. Pharm Res 2010;27:1080–91.
   PubMed Web of Science ®Google Scholar
• Bishayee A, Barnes KF, Bhatia D, Darvesh AS, Carroll RT. Resveratrol suppresses oxidative stress and inflammatory response in diethylnitrosamine-initiated rat hepatocarcinogenesis. Cancer Prev Res (Phila) 2010;3:753–63.
   PubMed Web of Science ®Google Scholar
• Bishayee A. Cancer prevention and treatment with resveratrol: from rodent studies to clinical trails. Cancer Prev Res (Phila) 2009;2:409–18.
   PubMed Web of Science ®Google Scholar
• Pignon JP, Bourhis J, Domenge C, Designe L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data MACH-NC Collaborative Group. MetaAnalysis of chemotherapy on head and neck cancer. Lancet 2000;355:949–55.
   PubMed Web of Science ®Google Scholar
• López-Jornet P, Camacho-Alonso F, Gómez-Garcia F. Effect of curcumin and irradiation in PE/CA-PJ15 oral squamous cell carcinoma. Acta Odontol Scand 2011;69:269–73.
   PubMed Web of Science ®Google Scholar
• Rashid A, Liu C, Sanli T, Tsiani E, Singh G, Bristow RG, et al. Resveratrol enhances prostate cancer cell response to ionizing radiation. Modulation of the AMPK, Akt and mTOR pathways. Radiat Oncol 2011;6:144.
   Google Scholar
• Zoberi I, Bradbury CM, Curry HA, Bisht KS, Goswami PC, Roti Roti JL, et al. Radiosensitizing and anti-proliferative effects of resveratrol in two human cervical tumor cell lines. Cancer Lett 2002;175:165–73.
   PubMed Web of Science ®Google Scholar
• Carmichael J, DeGraff WG, Gazdar AF, Minna JD, Mitchell JB. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res 1987;47:936–42.
   PubMed Web of Science ®Google Scholar
• Reagan-Shaw S, Mukhtar H, Ahmad N. Resveratrol imparts photoprotection if normal cells and enhances the efficacy of radiation therapy in cancer cells. Photochem Photobiol 2008;84:415–21.
   PubMed Web of Science ®Google Scholar
• Aziz MH, Reagan-Shaw S, Wu J, Longley BJ, Ahmad N. Chemoprevention on skin cancer by grape constituent resveratrol, relevance to human disease? FASEB J 2005;19:1193–5.
   PubMed Web of Science ®Google Scholar
• Gescher AJ, Steward WP. Relationship between mechanisms, bioavailability, and preclinical chemopreventive efficacy of resveratrol: a conundrum. Cancer Epidemiol Biomarkers Prev 2003;12:953–7.
   PubMed Web of Science ®Google Scholar
• Provinciali M, Re F, Donnini A, Orlando F, Bartozzi B, Di Stasio G, et al. Effect of resveratrol on the development of spontaneous mammary tumors in HER-2/neu transgenic mice. Int J Cancer 2005;115:36–45.
   PubMed Web of Science ®Google Scholar
• Berge G, Ovrebo S, Eilertsen E, Haugen A, Mollerup S. Analysis of resveratrol as a lung cancer chemopreventive agent in A/J mice exposed to benzo[a]pyrene. 2004;91:1380–3.
   Google Scholar